Efficacy of Quetiapine XR vs. Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar Disorder.
Phase of Trial: Phase III
Latest Information Update: 25 May 2015
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Therapeutic Use
- 01 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jan 2011 Actual initiation date (September 2010) added as reported by ClinicalTrials.gov.
- 04 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.